These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

414 related articles for article (PubMed ID: 26287983)

  • 1. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
    Prabhu RA; Nair S; Pai G; Reddy NP; Suvarna D
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD007003. PubMed ID: 26287983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interventions for dialysis patients with hepatitis C virus (HCV) infection.
    Prabhu AR; Rao IR; Nagaraju SP; Rajwar E; Venkatesh BT; Nair N S; Pai G; Reddy NP; Suvarna D
    Cochrane Database Syst Rev; 2023 Apr; 4(4):CD007003. PubMed ID: 37096802
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C.
    Hauser G; Awad T; Brok J; Thorlund K; Štimac D; Mabrouk M; Gluud C; Gluud LL
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005441. PubMed ID: 24585509
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacological interventions for acute hepatitis C infection: an attempted network meta-analysis.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2017 Mar; 3(3):CD011644. PubMed ID: 28285495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological interventions for acute hepatitis C infection.
    Kalafateli M; Buzzetti E; Thorburn D; Davidson BR; Tsochatzis E; Gurusamy KS
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD011644. PubMed ID: 30521693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiviral interventions for liver transplant patients with recurrent graft infection due to hepatitis C virus.
    Gurusamy KS; Tsochatzis E; Toon CD; Xirouchakis E; Burroughs AK; Davidson BR
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006803. PubMed ID: 24307460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aminoadamantanes for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010125. PubMed ID: 24793264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C.
    Hauser G; Awad T; Thorlund K; Štimac D; Mabrouk M; Gluud C
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD005642. PubMed ID: 24585451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aminoadamantanes versus other antiviral drugs for chronic hepatitis C.
    Lamers MH; Broekman M; Drenth JP; Gluud C
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD011132. PubMed ID: 24937404
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pegylated interferon alpha-2a and -2b in combination with ribavirin in the treatment of chronic hepatitis C: a systematic review and economic evaluation.
    Shepherd J; Brodin H; Cave C; Waugh N; Price A; Gabbay J
    Health Technol Assess; 2004 Oct; 8(39):iii-iv, 1-125. PubMed ID: 15461877
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiviral prophylaxis for the prevention of chronic hepatitis C virus in patients undergoing liver transplantation.
    Gurusamy KS; Tsochatzis E; Toon CD; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD006573. PubMed ID: 24297303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment for hepatitis C virus-associated mixed cryoglobulinaemia.
    Montero N; Favà A; Rodriguez E; Barrios C; Cruzado JM; Pascual J; Soler MJ
    Cochrane Database Syst Rev; 2018 May; 5(5):CD011403. PubMed ID: 29734473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon for interferon nonresponding and relapsing patients with chronic hepatitis C.
    Koretz RL; Pleguezuelo M; Arvaniti V; Barrera Baena P; Ciria R; Gurusamy KS; Davidson BR; Burroughs AK
    Cochrane Database Syst Rev; 2013 Jan; 2013(1):CD003617. PubMed ID: 23440791
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Peginterferon alfa and ribavirin for chronic hepatitis C in patients eligible for shortened treatment, re-treatment or in HCV/HIV co-infection: a systematic review and economic evaluation.
    Hartwell D; Jones J; Baxter L; Shepherd J
    Health Technol Assess; 2011 Apr; 15(17):i-xii, 1-210. PubMed ID: 21473834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitazoxanide for chronic hepatitis C.
    Nikolova K; Gluud C; Grevstad B; Jakobsen JC
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD009182. PubMed ID: 24706397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extended peginterferon plus ribavirin treatment for 72 weeks versus standard peginterferon plus ribavirin treatment for 48 weeks in chronic hepatitis C genotype 1 infected slow-responder adult patients.
    Katz LH; Goldvaser H; Gafter-Gvili A; Tur-Kaspa R
    Cochrane Database Syst Rev; 2012 Sep; 2012(9):CD008516. PubMed ID: 22972122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment for cryoglobulinemic and non-cryoglobulinemic peripheral neuropathy associated with hepatitis C virus infection.
    Benstead TJ; Chalk CH; Parks NE
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010404. PubMed ID: 25525951
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease.
    Saglimbene VM; Palmer SC; Ruospo M; Natale P; Craig JC; Strippoli GF
    Cochrane Database Syst Rev; 2017 Aug; 8(8):CD009904. PubMed ID: 28782299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.